Prostate cancer: open trials in Spain

102 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital de Jerez de la Frontera, Jerez de la Frontera · Hospital Universitario Lucus Augusti, Lugo · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Complejo Hospitalario Universitario de Ourense, Ourense · University Hospital Virgen Del Rocio S.L., Sevilla · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-11-05
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Trial Treatment · Phase 3 · ABX advanced biochemical compounds GmbH
Hospital Vall d'Hebron, Barcelona · Hospital del Mar, Barcelona · Hospital Vithas Valencia 9 de Octubre, Valencia
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Catalan Institute of Oncology Duran i Reynals Hospital, Barcelona · Hospital Madrid Norte Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen del Rocio, Seville
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-04
NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Quiron Dexeus Barcelona, Barcelona · South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
Registry updated 2026-11-04
NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Genentech, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clínico San Carlos, Madrid · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-11-03
NCT05818683
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de Jerez de la Frontera, Jerez de la Frontera · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Germans Trias i Pujol, Badalona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Morales Meseguer, Murcia · Hospital Universitario Virgen De La Macarena, Sevilla · Consorcio Hospital General Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-03
NCT07746713
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid
Registry updated 2026-11-03
NCT07888322
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Research · Aristotle University Of Thessaloniki
Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-02
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital del Mar, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Lucus Augusti, Lugo · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De Valme, Sevilla · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-10-30
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Hospital Clinic Barcelona, Barcelona · START Barcelona, Barcelona · START Rioja - Hospital de San Pedro, Logroño · NEXT Madrid HUQSM, Madrid · Hospital Universitari Son Espases, Palma · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-30
NCT05519449
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Trial Treatment · Phase 1 · Janux Therapeutics
Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario HM Sanchinarro, Madrid
Registry updated 2026-10-29
NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Barcelona · Madrid
Registry updated 2026-10-29
NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Barcelona · Logroño · Málaga
Registry updated 2026-10-28
NCT05997615
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Trial Treatment · Phase 1 · Astellas Pharma Global Development, Inc.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Fundacion Rioja Salud, Logrono · Clinica Universidad de Navarra, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Parc Tauli Hospital Universitari, Sabadell · Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga · Hospital Universitario Virgen Macarena, Seville · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-26
NCT07244341
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 1 · Daiichi Sankyo
Hospital Quirónsalud Barcelona, Barcelona · Hospital San Pedro, Logroño · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Registry updated 2026-10-26
2025-524080-20-00
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
Trial Treatment · Phase 1 · Novartis Pharma AG
Hospital Universitario Ramón y Cajal, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-23
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Madrid · Valencia
Registry updated 2026-10-23
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-10-22
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Hospital Clinic de Barcelona, Barcelona · Fundació Puigvert, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Quironsalud Malaga, Málaga · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Parc Tauli Hospital Universitari, Sabadell
Registry updated 2026-10-20

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error